Summary:
In overweight or obese adults aged 18–50 years, a standardized 60 mL daily hibiscus-inulin (HIB-INU) shot significantly reduced composite lipid-glucose indices (AIP and TyG) compared to a sensory-matched placebo, though it was associated with no significant effects on blood pressure parameters or reported adverse events.
| PICO | Description |
|---|---|
| Population | Adults aged 18–50 years with BMI ≥ 25 kg/m², indicating overweight or obesity (n = 100). |
| Intervention | Daily 60 mL shot of LC-MS-standardized Hibiscus-inulin (HIB-INU) beverage for 8 weeks. |
| Comparison | Sensory-matched placebo beverage taken daily over the same 8-week period. |
| Outcome | Significant reductions in Atherogenic Index of Plasma (AIP: -0.09; 95% CI -0.15 to -0.03; p = 0.004) and Triglyceride-Glucose Index (TyG: -0.14; 95% CI -0.26 to -0.03; p = 0.020) compared to placebo. No significant changes in mean arterial pressure (MAP) or pulse pressure (PP). Greater effects observed in participants with higher baseline cardiometabolic risk. |
Source: Mendivil, Edgar J., et al. “Standardized Hibiscus-Inulin Shot Lowers Lipid-Glucose Indices in Adults with Overweight and Obesity: 8-Week Randomized Trial.” Read article here.
